AVIR
Atea Pharmaceuticals, Inc. · Healthcare
Chief Development Officer Janet Mj Hammond sold $54K of Atea Pharmaceuticals, Inc.
Sold$53,913
$3.84Price
14,029Shares
−28%Stake
What AVIR did after the filing
- The stock from Mon, Feb 5 open, $4.06
- −3.0%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Feb 1. Filed Fri, Feb 2, 4:24 PM ET, after the close. Returns use the Feb 5 open and the Mar 19 close. Not investment advice.